Appeals & Response Plans
- Southern Africa: Armyworm Infestation - Jan 2017
- Southern Africa: Floods - Jan 2017
- Angola/DR Congo: Yellow Fever Outbreak - Jan 2016
- Southern Africa: Food Insecurity - 2015-2017
- Angola: Drought - 2012-2014
- Angola: Cholera Outbreak - Dec 2011
- Angola: Floods - Dec 2011
- Southern Africa: Floods - Jan 2011
- Angola: Floods - Oct 2010
- Angola: Floods - Mar 2010
Maps & Infographics
Most read reports
In a high-security building in Kampala, Uganda, a man leads a group of sleuths investigating a potential killer. While they may go about their work with the meticulousness of police detectives, they are actually a different type of investigator. Professor Moses Joloba, Director of Uganda's Supranational Reference Laboratory, leads his team to pursue TB – the world’s leading killer among infectious diseases. The disease killed more than 1.6 million people around the world in 2017.
The Global Fund and Angola signed a US$56 million agreement in June which consolidated all current malaria grants in the country into a single grant. The goal of the program, which has been supported by Chevron, is to reduce malaria-related morbidity by 60% in Angola by 2016.
Joint press release
NAIROBI, KENYA, 27, May 2010 - Government representatives from 20 African countries highly affected by HIV/AIDS gathered today in Nairobi to discuss ways to virtually eliminate mother-to-child transmission of HIV by 2015.
The three-day-consultation from 26 to 28 May is co-organized by the Global Fund to fight AIDS, Tuberculosis and Malaria and UN agencies, including UNAIDS, UNICEF, UNFPA and WHO. Participants are exploring how to expand and strengthen services for pregnant women and increase treatment for infected mothers and children.
88 Million Bed Nets Distributed for Malaria
Geneva - The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced that 2.3 million people living with HIV have been reached with lifesaving antiretroviral (ARV) treatment through AIDS programs it supports, a 31 per cent increase over results reported a year ago.
Global Fund-supported tuberculosis programs have so far put more than 5.4 million people on effective TB drugs treatment. Tuberculosis is the leading cause of death among HIV-infected people; the World Health Organization estimates that TB accounts for up to a …
This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown of the results by country, and answers to commonly-asked questions.
Question 1: How many people are receiving ARVs from programs supported by Global Fund grants?
As of June 1st 2009, programs supported by the Global Fund have reported 2.3 million people currently on ARVs for treatment of HIV/AIDS.
Question 2: What is the regional breakdown of people currently receiving ARVs?